E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 6/18/2015 in the Prospect News Distressed Debt Daily and Prospect News High Yield Daily.

Moody’s upgrades MedImpact

Moody's Investors Service said it upgraded MedImpact Holdings, Inc.'s corporate family rating to B2 from B3, probability of default rating to B2-PD from B3-PD and senior secured notes to Caa1 from Caa2.

The speculative grade liquidity rating was raised to SGL-2 from SGL-3.

The outlook is stable.

Moody’s said the upgrade reflects its belief that with recent improvements in EBITDA, the company will be able to sustain leverage below 4 times.

"MedImpact's leverage and cash flow metrics have improved following its acquisition of discount drug card businesses in 2013," Moody's vice president and senior credit officer Diana Lee said in a news release.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.